{"preliminary_commentary":{"by_channel":{"x_thread":33,"youtube":1,"podcast":1},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT01014130\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"drugs_tested":[],"indication":"inoperable stage I non-small cell lung cancer","name":"CHISEL","nct_id":"NCT01014130","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=chisel-nct01014130. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":1950,"size":"deep","size_rule":"Deep: 301+ verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"CHISEL","arms":[{"description":"Conventionally Fractionated Radiotherapy (ConRT) - Standard of Care","label":"Arm 2","type":"ACTIVE_COMPARATOR"},{"description":"Hypofractionated radiotherapy (HypoRT) - Investigational","label":"Arm 1","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2020-12","type":"ESTIMATED"},"conditions":["Non Small Cell Lung Cancer"],"enrollment":{"count":101,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Hypofractionated radiotherapy (HypoRT)","otherNames":["HypoRT","Radiotherapy","RT"],"type":"RADIATION"},{"name":"Conventionally Fractionated Radiotherapy (ConRT)","otherNames":["ConRT","Radiotherapy","RT"],"type":"RADIATION"}],"last_update":"2017-07-12","lead_sponsor":"Trans Tasman Radiation Oncology Group","official_title":"A Randomised Phase III Trial of Highly Conformal Hypofractionated Image Guided (\"Stereotactic\") Radiotherapy (HypoRT) Versus Conventionally Fractionated Radiotherapy (ConRT) for Inoperable Early Stage I Non-small Cell Lung Cancer (CHISEL)","overall_status":"UNKNOWN","phases":["PHASE3"],"primary_completion_date":{"date":"2020-12","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Time to Local Failure","timeFrame":"Completion of the two year follow up period for all patients."}],"references":[{"citation":"Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B; TROG 09.02 CHISEL investigators. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.","pmid":"30770291","type":"DERIVED"}],"start_date":{"date":"2009-12","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Hypofractionated Radiotherapy (Stereotactic) Versus Conventional Radiotherapy for Inoperable Early Stage I Non-small Cell Lung Cancer (NSCLC)","url":"https://clinicaltrials.gov/study/NCT01014130"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/chisel-nct01014130"}